CARE™ Congress 2020: Update on Biosimilars & Access to Innovation

Join us for the 4th National CARE™ Congress: Access to Innovation! This meeting addresses questions and considerations regarding Biosimilars in Canada and how they build towards a larger discussion on access to innovative medicine.

This meeting will include discussion and will provide a platform for medical specialists and key stakeholders across multiple fields to meet, collaborate, and discuss concepts that have a practical impact on the Canadian healthcare landscape.

The Aim:

The CARE™ Congress aims to allow assembled CARE™ faculty and panelists to consider the use of biosimilars and align on the importance of access to innovation.

The CARE™ Faculty is pleased to welcome a robust speaker line-up, with representation from Canadian researchers, clinicians, government, public and private funding agencies, and hospital pharmacists.

Leave a Comment

Your feedback is valuable for us. Your email will not be published.

Please wait...

Please leave these two fields as-is:
CARE™ Congress 2020: Update on Biosimilars & Access to Innovation